179 related articles for article (PubMed ID: 27535681)
1. Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance.
Thomas JD; Dattani A; Zemrak F; Burchell T; Akker SA; Gurnell M; Grossman AB; Davies LC; Korbonits M
Endocrine; 2016 Dec; 54(3):778-787. PubMed ID: 27535681
[TBL] [Abstract][Full Text] [Related]
2. Impaired cardiac performance in elderly patients with growth hormone deficiency.
Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
[TBL] [Abstract][Full Text] [Related]
3. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
4. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
[TBL] [Abstract][Full Text] [Related]
6. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
[TBL] [Abstract][Full Text] [Related]
7. Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study.
Capalbo D; Lo Vecchio A; Farina V; Spinelli L; Palladino A; Tiano C; Lettiero T; Lombardi G; Colao A; Salerno M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3347-55. PubMed ID: 19584193
[TBL] [Abstract][Full Text] [Related]
8. Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency.
De Cobelli F; Rossini A; Esposito A; Canu T; Manzoni G; Del Maschio A; Rubinacci A; Sirtori M; Losa M; Lanzi R; Perseghin G
Growth Horm IGF Res; 2019; 46-47():50-54. PubMed ID: 31276905
[TBL] [Abstract][Full Text] [Related]
9. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment.
Valcavi R; Gaddi O; Zini M; Iavicoli M; Mellino U; Portioli I
J Clin Endocrinol Metab; 1995 Feb; 80(2):659-66. PubMed ID: 7852533
[TBL] [Abstract][Full Text] [Related]
10. Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study.
Colao A; Cuocolo A; Di Somma C; Cerbone G; Morte AM; Pivonello R; Nicolai E; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Apr; 52(4):447-55. PubMed ID: 10762287
[TBL] [Abstract][Full Text] [Related]
11. Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.
Barker PC; Pasquali SK; Darty S; Ing RJ; Li JS; Kim RJ; DeArmey S; Kishnani PS; Campbell MJ
Mol Genet Metab; 2010 Dec; 101(4):332-7. PubMed ID: 20875764
[TBL] [Abstract][Full Text] [Related]
12. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
[TBL] [Abstract][Full Text] [Related]
13. Early-onset growth hormone deficiency results in diastolic dysfunction in adult-life and is prevented by growth hormone supplementation.
Groban L; Lin M; Kassik KA; Ingram RL; Sonntag WE
Growth Horm IGF Res; 2011 Apr; 21(2):81-8. PubMed ID: 21371927
[TBL] [Abstract][Full Text] [Related]
14. Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study.
Salerno M; Esposito V; Farina V; Radetti G; Umbaldo A; Capalbo D; Spinelli L; Muzzica S; Lombardi G; Colao A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1288-95. PubMed ID: 16403823
[TBL] [Abstract][Full Text] [Related]
15. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
[TBL] [Abstract][Full Text] [Related]
16. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
[TBL] [Abstract][Full Text] [Related]
17. Fat deposition in dilated cardiomyopathy assessed by CMR.
Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
[TBL] [Abstract][Full Text] [Related]
18. Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency.
Cho GY; Jeong IK; Kim SH; Kim MK; Park WJ; Oh DJ; Yoo HJ
Am J Cardiol; 2007 Sep; 100(6):1035-9. PubMed ID: 17826393
[TBL] [Abstract][Full Text] [Related]
19. Cardiac status after childhood growth hormone treatment of Turner syndrome.
van den Berg J; Bannink EM; Wielopolski PA; Hop WC; van Osch-Gevers L; Pattynama PM; de Muinck Keizer-Schrama SM; Helbing WA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2553-8. PubMed ID: 18430775
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone and the heart.
Saccà L; Cittadini A; Fazio S
Endocr Rev; 1994 Oct; 15(5):555-73. PubMed ID: 7843068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
